Sector Update: Health Care Stocks Advance Pre-Bell Monday

MT Newswires Live12-15 22:16

Health care stocks were advancing pre-bell Monday, with the iShares Biotechnology ETF (IBB) up 0.7% and the State Street Health Care Select Sector SPDR ETF (XLV) advancing by 0.4%.

Argenx (ARGX) shares were down nearly 6% after the company said it has discontinued a phase 3 study of its therapy subcutaneously administered efgartigimod in adults with moderate to severe thyroid eye disease.

Immunome (IMNM) stock was up nearly 20% after the company said its global pivotal phase 3 trial evaluating varegacestat, an investigational gamma secretase inhibitor, in patients with progressing desmoid tumors met its primary endpoint of improving progression-free survival.

Amphastar Pharmaceuticals (AMPH) shares were up more than 2% after the company said the US Food and Drug Administration approved the abbreviated New Drug Application for its teriparatide injection as a treatment for osteoporosis.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2591723644?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-15 22:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2591723644","market":"hk","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Advance Pre-Bell Monday","media":"MT Newswires Live","content":"<html><body><p> Health care stocks were advancing pre-bell Monday, with the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) up 0.7% and the State Street Health Care Select Sector SPDR ETF (XLV) advancing by 0.4%.</p><p>Argenx (ARGX) shares were down nearly 6% after the company said it has discontinued a phase 3 study of its therapy subcutaneously administered efgartigimod in adults with moderate to severe thyroid eye disease.</p><p>Immunome (IMNM) stock was up nearly 20% after the company said its global pivotal phase 3 trial evaluating varegacestat, an investigational gamma secretase inhibitor, in patients with progressing desmoid tumors met its primary endpoint of improving progression-free survival.</p><p><a href=\"https://laohu8.com/S/AMPH\">Amphastar Pharmaceuticals</a> (AMPH) shares were up more than 2% after the company said the US Food and Drug Administration approved the abbreviated New Drug Application for its teriparatide injection as a treatment for osteoporosis.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Advance Pre-Bell Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Advance Pre-Bell Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-15 22:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks were advancing pre-bell Monday, with the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) up 0.7% and the State Street Health Care Select Sector SPDR ETF (XLV) advancing by 0.4%.</p><p>Argenx (ARGX) shares were down nearly 6% after the company said it has discontinued a phase 3 study of its therapy subcutaneously administered efgartigimod in adults with moderate to severe thyroid eye disease.</p><p>Immunome (IMNM) stock was up nearly 20% after the company said its global pivotal phase 3 trial evaluating varegacestat, an investigational gamma secretase inhibitor, in patients with progressing desmoid tumors met its primary endpoint of improving progression-free survival.</p><p><a href=\"https://laohu8.com/S/AMPH\">Amphastar Pharmaceuticals</a> (AMPH) shares were up more than 2% after the company said the US Food and Drug Administration approved the abbreviated New Drug Application for its teriparatide injection as a treatment for osteoporosis.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0109394709.USD","symbol_name":"富兰克林生物科技新领域基金A (acc)","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2591723644","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2591723644","pubTimestamp":1765808171,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks were advancing pre-bell Monday, with the iShares Biotechnology ETF  up 0.7% and the State Street Health Care Select Sector SPDR ETF  advancing by 0.4%.Argenx  shares were down nearly 6% after the company said it has discontinued a phase 3 study of its therapy subcutaneously administered efgartigimod in adults with moderate to severe thyroid eye disease.Immunome  stock was up nearly 20% after the company said its global pivotal phase 3 trial evaluating varegacestat, an investigational gamma secretase inhibitor, in patients with progressing desmoid tumors met its primary endpoint of improving progression-free survival.Amphastar Pharmaceuticals  shares were up more than 2% after the company said the US Food and Drug Administration approved the abbreviated New Drug Application for its teriparatide injection as a treatment for osteoporosis.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LABU":"三倍做多标普生物-Direxion","XLV":"健康照护类股ETF-SPDR","XBI":"SPDR S&P Biotech ETF","IMNM":"Immunome Inc.","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","BK4505":"高瓴资本持仓","BK4557":"大麻股","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","BK4581":"高盛持仓","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU1983260115.SGD":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","BK4588":"碎股","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","IBB":"生物科技指数ETF-iShares Nasdaq","BK4007":"制药","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","AMPH":"Amphastar Pharmaceuticals","ARGX":"Argenx SE","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BK4585":"ETF&股票定投概念","BK4563":"昨日强势股","BK4139":"生物科技"},"translate_title":"行业更新：医疗保健股周一上涨盘前","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XBI":0.6,"XLV":1,"IMNM":1,"IBB":1,"AMPH":1,"ARGX":1,"LABU":0.6},"content_text":"Health care stocks were advancing pre-bell Monday, with the iShares Biotechnology ETF (IBB) up 0.7% and the State Street Health Care Select Sector SPDR ETF (XLV) advancing by 0.4%.Argenx (ARGX) shares were down nearly 6% after the company said it has discontinued a phase 3 study of its therapy subcutaneously administered efgartigimod in adults with moderate to severe thyroid eye disease.Immunome (IMNM) stock was up nearly 20% after the company said its global pivotal phase 3 trial evaluating varegacestat, an investigational gamma secretase inhibitor, in patients with progressing desmoid tumors met its primary endpoint of improving progression-free survival.Amphastar Pharmaceuticals (AMPH) shares were up more than 2% after the company said the US Food and Drug Administration approved the abbreviated New Drug Application for its teriparatide injection as a treatment for osteoporosis.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2591723644","isCrawlerRequest":true}